152 related articles for article (PubMed ID: 31104627)
1. Lessons from Alzheimer's Disease (AD) Clinical Trials: Instead of "A-Drug", AD-D prevention to Avert AD.
Lahiri DK
Curr Alzheimer Res; 2019; 16(4):279-280. PubMed ID: 31104627
[No Abstract] [Full Text] [Related]
2. Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease.
Carrillo MC; Brashear HR; Logovinsky V; Ryan JM; Feldman HH; Siemers ER; Abushakra S; Hartley DM; Petersen RC; Khachaturian AS; Sperling RA
Alzheimers Dement; 2013 Mar; 9(2):123-131.e1. PubMed ID: 23411394
[TBL] [Abstract][Full Text] [Related]
3. Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
Wang J; Tan L; Yu JT
J Alzheimers Dis; 2016; 50(4):927-45. PubMed ID: 26836177
[TBL] [Abstract][Full Text] [Related]
4. Prevention therapeutics of dementia.
Schneider LS
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S122-30. PubMed ID: 18631988
[TBL] [Abstract][Full Text] [Related]
5. Drug discovery and the prevention of Alzheimer's disease.
Fillit H
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S26-8. PubMed ID: 18631996
[TBL] [Abstract][Full Text] [Related]
6. Prevention studies in Alzheimer's disease: progress towards the development of new therapeutics.
Coley N; Gallini A; Andrieu S
CNS Drugs; 2015 Jul; 29(7):519-28. PubMed ID: 26188654
[TBL] [Abstract][Full Text] [Related]
7. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
Vermunt L; Veal CD; Ter Meulen L; Chrysostomou C; van der Flier W; Frisoni GB; Guessous I; Kivipelto M; Marizzoni M; Martinez-Lage P; Molinuevo JL; Porteous D; Ritchie K; Scheltens P; Ousset PJ; Ritchie CW; Luscan G; Brookes AJ; Visser PJ
Alzheimers Dement; 2018 Jun; 14(6):837-842. PubMed ID: 29604264
[TBL] [Abstract][Full Text] [Related]
8. EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.
Aisen P; Touchon J; Amariglio R; Andrieu S; Bateman R; Breitner J; Donohue M; Dunn B; Doody R; Fox N; Gauthier S; Grundman M; Hendrix S; Ho C; Isaac M; Raman R; Rosenberg P; Schindler R; Schneider L; Sperling R; Tariot P; Welsh-Bohmer K; Weiner M; Vellas B
J Prev Alzheimers Dis; 2017; 4(2):116-124. PubMed ID: 29186281
[TBL] [Abstract][Full Text] [Related]
9. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
Doody RS
Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
[TBL] [Abstract][Full Text] [Related]
10. Chronic disease long-term drug prevention trials: lessons from the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).
Meinert CL; Breitner JC
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S7-S14. PubMed ID: 18632005
[TBL] [Abstract][Full Text] [Related]
11. Preventing cognitive decline in preclinical Alzheimer's disease.
Riedel WJ
Curr Opin Pharmacol; 2014 Feb; 14():18-22. PubMed ID: 24565007
[TBL] [Abstract][Full Text] [Related]
12. Memory health clinics-a first step to prevention.
Vellas B; Gillette-Guyonnet S; Andrieu S
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S144-9. PubMed ID: 18631991
[TBL] [Abstract][Full Text] [Related]
13. Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?
Messner DA; Rabins P; Downing AC; Irizarry M; Foster NL; Al Naber J; Dabbous O; Fillit H; Gabler S; Krakauer R; Lotz D; Payzant E; Schneider L; Tyrone J; Van Amerongen D; Wuest D
J Prev Alzheimers Dis; 2019; 6(1):20-26. PubMed ID: 30569082
[TBL] [Abstract][Full Text] [Related]
14. Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials.
Weninger S; Carrillo MC; Dunn B; Aisen PS; Bateman RJ; Kotz JD; Langbaum JB; Mills SL; Reiman EM; Sperling R; Santacruz AM; Tariot PN; Welsh-Bohmer KA
Alzheimers Dement; 2016 May; 12(5):631-2. PubMed ID: 27157073
[No Abstract] [Full Text] [Related]
15. Prevention of Alzheimer's Disease: Lessons Learned and Applied.
Galvin JE
J Am Geriatr Soc; 2017 Oct; 65(10):2128-2133. PubMed ID: 28766695
[TBL] [Abstract][Full Text] [Related]
16. Authors response to D Umbricht, letter to the editor referring Futility Analyses in Alzheimer's Disease (AD) Clinical Trials: A Risky Business. The Journal of Prevention of Alzheimer's Disease, 2020.
Aisen PS; Raman R
J Prev Alzheimers Dis; 2020; 7(4):300. PubMed ID: 32920636
[No Abstract] [Full Text] [Related]
17. Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer's disease: dissecting the epidemiological evidence.
Launer L
Drugs; 2003; 63(8):731-9. PubMed ID: 12662122
[TBL] [Abstract][Full Text] [Related]
18. Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward.
Hsu D; Marshall GA
Curr Alzheimer Res; 2017; 14(4):426-440. PubMed ID: 27697063
[TBL] [Abstract][Full Text] [Related]
19. Effects of Tea Catechins on Alzheimer's Disease: Recent Updates and Perspectives.
Ide K; Matsuoka N; Yamada H; Furushima D; Kawakami K
Molecules; 2018 Sep; 23(9):. PubMed ID: 30223480
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease prevention: from risk factors to early intervention.
Crous-Bou M; Minguillón C; Gramunt N; Molinuevo JL
Alzheimers Res Ther; 2017 Sep; 9(1):71. PubMed ID: 28899416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
